Status | Study |
Completed |
Study Name: Epithelioid Hemangioma of Bone And Soft Tissue Condition: Epithelioid Hemangioma of Bone Epithelioid Hemangioma Date: 2017-05-17 Interventions: Procedure: Surgery Patients affected by epithelioid hemangioma treated with surgery |
Recruiting |
Study Name: TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial Condition: Multicentric Castleman Disease Date: 2017-01-31 Interventions: Drug: Thalidomide, cyclophosphamide and prednisone |
Recruiting |
Study Name: Castleman Disease Collaborative Network Biobank Condition: Castleman Disease Castleman's Disease Date: 2016-08-15 Interventions: Other: Sample Collection Excess blood sample tubes and/or buccal swabs or saliva will have DNA and RNA e |
Recruiting |
Study Name: Unlock the Cell: Castleman's Disease Flow Cytometry Study Condition: Castleman Disease Angiofollicular Lymphoi Date: 2016-07-15 Interventions: Procedure: Blood draw/buccal swab The research project will need a blood sample of no more than 50mL per |
Recruiting |
Study Name: International Registry for Patients With Castleman Disease Condition: Castleman Disease Castleman's Disease Date: 2016-06-22 |
Recruiting |
Study Name: Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma Condition: Kaposi Sarcoma Date: 2016-01-20 Interventions: Drug: liposomal doxorubicin li |
Withdrawn |
Study Name: Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas Condition: Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease Date: 2014-08-27 Interventions: Drug: Pomalidomide Part A: 5 m |
Terminated |
Study Name: Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection Condition: Adult B Acute Lymphoblastic Leukemia Chronic Lymphocytic Leukemia Date: 2014-04-07 Interventions: Drug: Ibrutinib Given PO |
Terminated |
Study Name: Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors Condition: Non-Hodgkin Lymphoma Hodgkin Lymphoma Kaposi Sarcoma Date: 2014-03-04 Interventions: Drug: Nelfinavir Nelfinavir will be given 3000 mg orally twice daily on days 1-14 of a 14-day cycle. NFV |
Recruiting |
Study Name: Tocilizumab for KSHV-Associated Multicentric Castleman Disease Condition: Castleman Disease Castleman's Disease Date: 2011-09-24 Interventions: Drug: Zidovudine Zidovudine (A |